Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Method and apparatus for supporting delivery, sale and billing of perishable and time-sensitive goods such as newspapers, periodicals and direct marketing and promotional materials
Anti-infective agents and uses thereof
Pet urn enclosure
Topical antibiotic composition for the prevention of Lyme disease
Controller for soldering iron
Method and apparatus for detection of the remote origin fraction of radon present in a measuring site
  Randomly Featured Patents
Position display apparatus
Portion of a matrix for surface mount package leadframe
Pet chew toy
Fuel offering and purchase management system
Cork extracting device and bottle system
Sequence allocating method, transmitting method and wireless mobile station device
Heterocyclic cycloalkanes
Case for an instrument of small volume including a manually removable back cover
Process and apparatus for transferring information between an information store and a data channel
Method and apparatus for removing liners from metal closures